rxstat › Shortages › Oxazepam
Oxazepam shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Oxazepam is in a widespread shortage in Canada. 6 of 10 reported products are affected. Manufacturers have not committed to a recovery date.
In shortage since
Feb 27, 2012
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageOXPAM
BIOMED PHARMA
DIN 00414263 · since Oct 23, 2014, no end estimate · Other (Please describe in comments)
Active shortageOXPAM
BIOMED PHARMA
DIN 00414263 · since Oct 23, 2014, no end estimate · Other (Please describe in comments)
Active shortageOXPAM
BIOMED PHARMA
DIN 00414255 · since Oct 23, 2014, no end estimate · Other (Please describe in comments)
Active shortageOXPAM
BIOMED PHARMA
DIN 00414255 · since Oct 23, 2014, no end estimate · Other (Please describe in comments)
Active shortageOXPAM
BIOMED PHARMA
DIN 00414247 · since Oct 23, 2014, no end estimate · Other (Please describe in comments)
Active shortageOXPAM
BIOMED PHARMA
DIN 00414247 · since Oct 23, 2014, no end estimate · Other (Please describe in comments)
Active shortageBIO-OXAZEPAM
BIOMED PHARMA
DIN 02247179 · since Feb 27, 2012, no end estimate · Other (Please describe in comments)
Active shortageBIO-OXAZEPAM
BIOMED PHARMA
DIN 02247178 · since Feb 28, 2012, no end estimate · Other (Please describe in comments)
Active shortageBIO-OXAZEPAM
BIOMED PHARMA
DIN 02247177 · since Feb 28, 2012, no end estimate · Other (Please describe in comments)
ResolvedAPO-OXAZEPAM
30MG · TABLET · APOTEX INC
DIN 00402737 · ended Aug 28, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-OXAZEPAM
10MG · TABLET · APOTEX INC
DIN 00402680 · ended Sep 19, 2022 · Disruption of the manufacture of the drug.
DiscontinuedAPO OXAZEPAM TAB 10MG
10MG · TABLET · APOTEX INC
DIN 00402680
Showing 12 of 19 reports. All reports are on file with Health Canada.
What's happening
Oxazepam is currently affected by 6 active shortage reports filed with Health Canada by BIOMED PHARMA.
The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Oxazepam is classified under “ANXIOLYTICS” (ATC N05BA).
Recent changes
Common questions
When will Oxazepam be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Oxazepam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.